Nontraditional Manifestations of Primary Hyperparathyroidism

Journal of Clinical Densitometry

Volumn 16, Issue 1, 2013, Pages 40-47

  Walker, Marcella Donovan ^a   Rubin, Mishaela ^a   Silverberg, Shonni J ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Cardiovascular; Cognitive; Primary hyperparathyroidism; Psychological

Indexed keywords

ARTICLE; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COGNITION; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART CALCIFICATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; NEOPLASM; NEPHROLITHIASIS; NEUROPSYCHOLOGY; OBSERVATIONAL STUDY; OSTEITIS FIBROSA; PARATHYROIDECTOMY; PHENOTYPE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATIC DISEASE; TREATMENT INDICATION; VASCULAR DISEASE;

ASYMPTOMATIC DISEASES; BONE DENSITY; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERTROPHY, LEFT VENTRICULAR; QUALITY OF LIFE;

EID: 84873168489     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2012.11.008     Document Type: Article

References (95)

1. Khoo T.K., Vege S.S., Abu-Lebdeh H.S., et al. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 2009, 94(6):2115-2118.
2. Rubin M.R., Silverberg S.J. Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy. Curr Rheumatol Rep 2002, 4(2):179-185.
3. Silverberg S.J., Lewiecki E.M., Mosekilde L., et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94(2):351-365.
4. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009, 94(2):335-339.
5. Brown G.G., Preisman R.C., Kleerekoper M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 1987, 35(4):211-215.
6. Burney R.E., Jones K.R., Christy B., Thompson N.W. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 1999, 125(6):608-614.
7. Caillard C., Sebag F., Mathonnet M., et al. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 2007, 141(2):153-159. discussion 159-160.
8. Dotzenrath C.M., Kaetsch A.K., Pfingsten H., et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 2006, 5:680-685.
9. Eigelberger M.S., Cheah W.K., Ituarte P.H., et al. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?. Ann Surg 2004, 239(4):528-535.
10. Joborn C., Hetta J., Lind L., et al. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989, 105(1):72-78.
11. Numann P.J., Torppa A.J., Blumetti A.E. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery 1984, 96(6):1119-1123.
12. Pasieka J.L., Parsons L.L. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 1998, 22(6):513-518. discussion 518-519.
13. Prager G., Kalaschek A., Kaczirek K., et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 2002, 132(6):930-935. discussion 935-936.
14. Roman S.A., Sosa J.A., Mayes L., et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005, 138(6):1121-1128. discussion 1128-1129.
15. Solomon B.L., Schaaf M., Smallridge R.C. Psychologic symptoms before and after parathyroid surgery. Am J Med 1994, 96(2):101-106.
16. Espiritu R.P., Kearns A.E., Vickers K.S., et al. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 2011, 96(11):E1737-E1745.
17. Walker M.D., McMahon D.J., Inabnet W.B., et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 2009, 94(6):1951-1958.
18. Chiang C.Y., Andrewes D.G., Anderson D., et al. A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin Endocrinol (Oxf) 2005, 62(1):99-104.
19. Pasieka J.L., Parsons L.L., Demeure M.J., et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 2002, 26(8):942-949.
20. Sheldon D.G., Lee F.T., Neil N.J., Ryan J.A. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 2002, 137(9):1022-1026. discussion 1026-1028.
21. Quiros R.M., Alef M.J., Wilhelm S.M., et al. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 2003, 134(4):675-681. discussion 681-683.
22. Amstrup A.K., Rejnmark L., Mosekilde L. Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol 2011, 165(5):753-760.
23. Rao D.S., Phillips E.R., Divine G.W., Talpos G.B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004, 89(11):5415-5422.
24. Bollerslev J., Jansson S., Mollerup C.L., et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007, 92(5):1687-1692.
25. Ambrogini E., Cetani F., Cianferotti L., et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 2007, 92(8):3114-3121.
26. Benge J.F., Perrier N.D., Massman P.J., et al. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc 2009, 15(6):1002-1011.
27. Roman S.A., Sosa J.A., Pietrzak R.H., et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 2011, 253(1):131-137.
28. Cogan M.G., Covey C.M., Arieff A.I., et al. Central nervous system manifestations of hyperparathyroidism. Am J Med 1978, 65(6):963-970.
29. Goyal A., Chumber S., Tandon N., et al. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J Med Sci 2001, 55(12):677-686.
30. Perrier N.D., Balachandran D., Wefel J.S., et al. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery 2009, 146(6):1116-1122.
31. Palmer M., Adami H.O., Bergstrom R., et al. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987, 102(1):1-7.
32. Ronni-Sivula H. Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985, 74(1):13-18.
33. Ljunghall S., Jakobsson S., Joborn C., et al. Longitudinal studies of mild primary hyperparathyroidism. J Bone Miner Res 1991, 6(Suppl 2):S111-S116. discussion S121-S124.
34. Hedback G., Tisell L.E., Bengtsson B.A., et al. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 1990, 14(6):829-835. discussion 836.
35. Ogard C.G., Engholm G., Almdal T.P., Vestergaard H. Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 2004, 28(1):108-111.
36. Hedback G., Oden A., Tisell L.E. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991, 15(3):399-405. discussion 406-407.
37. Soreide J.A., van Heerden J.A., Grant C.S., et al. Survival after surgical treatment for primary hyperparathyroidism. Surgery 1997, 122(6):1117-1123.
38. Wermers R.A., Khosla S., Atkinson E.J., et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998, 104(2):115-122.
39. Nilsson I.L., Yin L., Lundgren E., et al. Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 2002, 17(Suppl 2):N68-N74.
40. Hedback G., Oden A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 1998, 28(4):271-276.
41. Vestergaard P., Mollerup C.L., Frokjaer V.G., et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003, 27(2):216-222.
42. Yu N., Donnan P.T., Flynn R.W., et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 2010, 73(1):30-34.
43. Heyliger A., Tangpricha V., Weber C., Sharma J. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 2009, 146(6):1042-1047.
44. Nainby-Luxmoore J.C., Langford H.G., Nelson N.C., et al. A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 1982, 55(2):303-306.
45. Ringe J.D. Reversible hypertension in primary hyperparathyroidism-pre- and postoperative blood pressure in 75 cases. Klin Wochenschr 1984, 62(10):465-469.
46. Persson A., Bollerslev J., Rosen T., et al. Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clin Endocrinol (Oxf) 2011, 74(2):174-180.
47. Roberts W.C., Waller B.F. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 1981, 71(3):371-384.
48. Streeten E.A., Munir K., Hines S., et al. Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis. Endocr Pract 2008, 14(2):155-161.
49. Nilsson I.L., Aberg J., Rastad J., Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery 2005, 137(6):632-638.
50. Marini C., Giusti M., Armonino R., et al. Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2010, 37(12):2256-2263.
51. Stefenelli T., Mayr H., Bergler-Klein J., et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993, 95(2):197-202.
52. Dalberg K., Brodin L.A., Juhlin-Dannfelt A., Farnebo L.O. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 1996, 162(3):171-176.
53. Iwata S., Walker M.D., Di Tullio M.R., et al. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2012, 97(1):132-137.
54. Nuzzo V., Tauchmanova L., Fonderico F., et al. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 2002, 147(4):453-459.
55. Nilsson I.L., Aberg J., Rastad J., Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 2000, 128(6):895-902.
56. Piovesan A., Molineri N., Casasso F., et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999, 50(3):321-328.
57. Almqvist E.G., Bondeson A.G., Bondeson L., et al. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 2002, 132(6):1126-1132. discussion 1132.
58. Farahnak P., Ring M., Caidahl K., et al. Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur J Endocrinol 2010, 163(3):461-467.
59. Walker M.D., Fleischer J.B., Di Tullio M.R., et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2010, 95(5):2172-2179.
60. Lind L., Ridefelt P., Rastad J., et al. Cytoplasmic calcium regulation and the electrocardiogram in patients with primary hyperparathyroidism. Clin Physiol 1994, 14(1):103-110.
61. Rosenqvist M., Nordenstrom J., Andersson M., Edhag O.K. Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism. Clin Endocrinol (Oxf) 1992, 37(1):29-33.
62. Barletta G., De Feo M.L., Del Bene R., et al. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85(5):1815-1821.
63. Curione M., Letizia C., Amato S., et al. Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability?. Int J Cardiol 2007, 121(2):200-202.
64. Baykan M., Erem C., Erdogan T., et al. Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 2007, 66(4):483-488.
65. Walker M.D., Fleischer J., Rundek T., et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009, 94(10):3849-3856.
66. Kiris A., Erem C., Kiris G., et al. The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography 2011, 28(9):955-960.
67. Nilsson I.L., Aberg J., Rastad J., Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999, 126(6):1049-1055.
68. Kosch M., Hausberg M., Vormbrock K., et al. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000, 13(7):759-764.
69. Lumachi F., Ermani M., Frego M., et al. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up. In Vivo 2006, 20(6B):887-890.
70. Fallo F., Camporese G., Capitelli E., et al. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88(5):2096-2099.
71. Neunteufl T., Katzenschlager R., Abela C., et al. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998, 40(2):396-401.
72. Kosch M., Hausberg M., Vormbrock K., et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000, 47(4):813-818.
73. Baykan M., Erem C., Erdogan T., et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007, 23(3):323-328.
74. Rosa J., Raska I., Wichterle D., et al. Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens Res 2011, 34(3):296-300.
75. Schillaci G., Pucci G., Pirro M., et al. Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 2011, 218(1):96-101.
76. Smith J.C., Page M.D., John R., et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85(10):3515-3519.
77. Rubin M.R., Maurer M.S., McMahon D.J., et al. Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90(6):3326-3330.
78. Bolland M.J., Grey A.B., Gamble G.D., Reid I.R. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005, 90(3):1525-1530.
79. Han D., Trooskin S., Wang X. Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J Endocrinol Invest 2012, 35(6):548-552.
80. Kumar S., Olukoga A.O., Gordon C., et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1994, 40(1):47-53.
81. Grethen E., Hill K.M., Jones R., et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 2012, 97(5):1655-1662.
82. Luboshitzky R., Chertok-Schaham Y., Lavi I., Ishay A. Cardiovascular risk factors in primary hyperparathyroidism. J Endocrinol Invest 2009, 32(4):317-321.
83. Almqvist E.G., Bondeson A.G., Bondeson L., Svensson J. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Invest 2011, 71(2):139-144.
84. Bhadada S.K., Bhansali A., Shah V.N., Rao D.S. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Singapore Med J 2011, 52(12):890-893.
85. Farahnak P., Larfars G., Sten-Linder M., Nilsson I.L. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab 2011, 96(7):2112-2118.
86. Bollerslev J., Rosen T., Mollerup C.L., et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009, 94(7):2255-2261.
87. Broulik P.D., Stepan J.J., Pacovsky V. Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover. Clin Chim Acta 1987, 170(2-3):195-200.
88. Rynes R.I., Merzig E.G. Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study. J Rheumatol 1978, 5(4):460-468.
89. Alexander G.M., Dieppe P.A., Doherty M., Scott D.G. Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann Rheum Dis 1982, 41(4):377-381.
90. Bilezikian J.P., Connor T.B., Aptekar R., et al. Pseudogout after parathyroidectomy. Lancet 1973, 1(7801):445-446.
91. Silverberg S.J. Non-classical target organs in primary hyperparathyroidism. J Bone Miner Res 2002, 17(Suppl 2):N117-N125.
92. Ludvigsson J.F., Kampe O., Lebwohl B., et al. Primary hyperparathyroidism and celiac disease: a population-based cohort study. J Clin Endocrinol Metab 2012, 97(3):897-904.
93. Pickard A.L., Gridley G., Mellemkjae L., et al. Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer 2002, 95(8):1611-1617.
94. Michels K.B., Xue F., Brandt L., Ekbom A. Hyperparathyroidism and subsequent incidence of breast cancer. Int J Cancer 2004, 110(3):449-451.
95. Palmer M., Adami H.O., Krusemo U.B., Ljunghall S. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 1988, 127(5):1031-1040.